MYCO-004 is a patch-delivered psychedelic tryptamine which is under development for the treatment of psychiatric disorders.
[2][3][1] It is anticipated to allow for precision dosing and to have a short duration of approximately 2 hours.
[4] The drug is being developed by Mydecine.
[2][3] As of December 2021, it is in preclinical research for psychiatric disorders.
[2][3] The exact chemical structure of MYCO-004 does not yet seem to have been disclosed.